JP2013526572A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013526572A5 JP2013526572A5 JP2013511293A JP2013511293A JP2013526572A5 JP 2013526572 A5 JP2013526572 A5 JP 2013526572A5 JP 2013511293 A JP2013511293 A JP 2013511293A JP 2013511293 A JP2013511293 A JP 2013511293A JP 2013526572 A5 JP2013526572 A5 JP 2013526572A5
- Authority
- JP
- Japan
- Prior art keywords
- polymer compound
- vinyl acetate
- eye
- ethylene
- compound part
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 24
- 229920000642 polymer Polymers 0.000 claims 21
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 claims 6
- 239000005038 ethylene vinyl acetate Substances 0.000 claims 6
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims 6
- 239000013543 active substance Substances 0.000 claims 5
- 229920003176 water-insoluble polymer Polymers 0.000 claims 4
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims 3
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 claims 2
- 210000000795 conjunctiva Anatomy 0.000 claims 2
- 239000004715 ethylene vinyl alcohol Substances 0.000 claims 2
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 claims 2
- HNPFPERDNWXAGS-NFVOFSAMSA-N latanoprost free acid Chemical class C([C@@H](O)CCC=1C=CC=CC=1)C[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O HNPFPERDNWXAGS-NFVOFSAMSA-N 0.000 claims 2
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 claims 1
- KIQXRQVVYTYYAZ-MTNCBHNASA-N Tafluprost free acid Chemical class OC(=O)CCC\C=C/CC1C(O)CC(O)C1\C=C\C(F)(F)COC1=CC=CC=C1 KIQXRQVVYTYYAZ-MTNCBHNASA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 1
- 229960002470 bimatoprost Drugs 0.000 claims 1
- AQOKCDNYWBIDND-FTOWTWDKSA-N bimatoprost Chemical compound CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1 AQOKCDNYWBIDND-FTOWTWDKSA-N 0.000 claims 1
- 238000010828 elution Methods 0.000 claims 1
- WWSWYXNVCBLWNZ-QIZQQNKQSA-N fluprostenol Chemical class C([C@H](O)\C=C\[C@@H]1[C@H]([C@@H](O)C[C@H]1O)C\C=C/CCCC(O)=O)OC1=CC=CC(C(F)(F)F)=C1 WWSWYXNVCBLWNZ-QIZQQNKQSA-N 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 229960001160 latanoprost Drugs 0.000 claims 1
- GGXICVAJURFBLW-CEYXHVGTSA-N latanoprost Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1 GGXICVAJURFBLW-CEYXHVGTSA-N 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 210000003786 sclera Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34554710P | 2010-05-17 | 2010-05-17 | |
| US61/345,547 | 2010-05-17 | ||
| PCT/US2011/036806 WO2011146483A1 (en) | 2010-05-17 | 2011-05-17 | Drug delivery devices for delivery of ocular therapeutic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013526572A JP2013526572A (ja) | 2013-06-24 |
| JP2013526572A5 true JP2013526572A5 (enExample) | 2014-07-03 |
Family
ID=44992020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013511293A Pending JP2013526572A (ja) | 2010-05-17 | 2011-05-17 | 眼治療薬の送達のための薬物送達装置 |
Country Status (6)
| Country | Link |
|---|---|
| US (6) | US20130142858A1 (enExample) |
| EP (1) | EP2571526B1 (enExample) |
| JP (1) | JP2013526572A (enExample) |
| AU (1) | AU2011256259A1 (enExample) |
| CA (1) | CA2798084A1 (enExample) |
| WO (1) | WO2011146483A1 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
| US12478503B2 (en) | 2009-05-18 | 2025-11-25 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
| CA2762536C (en) | 2009-05-18 | 2019-05-21 | Dose Medical Corporation | Drug eluting ocular implant |
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| AU2010256558B2 (en) | 2009-06-03 | 2013-10-03 | Forsight Labs, Llc | Anterior segment drug delivery |
| EP2571526B1 (en) | 2010-05-17 | 2019-03-13 | Novaer Holdings, Inc. | Drug delivery devices for delivery of ocular therapeutic agents |
| EP2654715B1 (en) | 2010-11-24 | 2017-01-25 | Dose Medical Corporation | Drug eluting ocular implant |
| US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
| US9873765B2 (en) | 2011-06-23 | 2018-01-23 | Dsm Ip Assets, B.V. | Biodegradable polyesteramide copolymers for drug delivery |
| EP4406558A3 (en) | 2011-06-23 | 2024-10-23 | DSM IP Assets B.V. | New biodegradable polyesteramide copolymers for drug delivery |
| US9102105B2 (en) * | 2011-09-13 | 2015-08-11 | Vista Scientific Llc | Method for forming an ocular drug delivery device |
| KR102192603B1 (ko) | 2011-09-14 | 2020-12-17 | 포사이트 비젼5, 인크. | 안내 삽입물 장치 및 방법 |
| WO2013087903A1 (en) * | 2011-12-16 | 2013-06-20 | Dsm Ip Assets B.V. | Process for the manufacturing of a drug delivery system based on a polymer comprising a dispersed bioactive agent |
| US8900300B1 (en) | 2012-02-22 | 2014-12-02 | Omega Ophthalmics Llc | Prosthetic capsular bag and method of inserting the same |
| WO2014053542A1 (en) | 2012-10-02 | 2014-04-10 | Dsm Ip Assets B.V. | Drug delivery composition comprising proteins and biodegradable polyesteramides |
| RU2652063C2 (ru) | 2012-10-26 | 2018-04-24 | Форсайт Вижн5, Инк. | Офтальмологическая система для замедленного высвобождения лекарственного средства в глазу |
| US10098836B2 (en) | 2013-05-02 | 2018-10-16 | Retina Foundation Of The Southwest | Method for forming a molded two-layer ocular implant |
| US20150342875A1 (en) | 2014-05-29 | 2015-12-03 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| CA2952809C (en) | 2014-06-19 | 2019-11-26 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
| JP6686023B2 (ja) * | 2014-11-25 | 2020-04-22 | エキシモア・リミテッドＥｘｉｍｏｒｅ Ｌｔｄ． | 生物活性剤または生物活性剤類を送達する組成物および方法 |
| US10434071B2 (en) | 2014-12-18 | 2019-10-08 | Dsm Ip Assets, B.V. | Drug delivery system for delivery of acid sensitivity drugs |
| US9358103B1 (en) | 2015-02-10 | 2016-06-07 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
| US20160296532A1 (en) | 2015-04-13 | 2016-10-13 | Forsight Vision5, Inc. | Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent |
| US20180280194A1 (en) * | 2015-05-20 | 2018-10-04 | Glaukos Corporation | Therapeutic drug compositions and implants for delivery of same |
| WO2017040853A1 (en) | 2015-09-02 | 2017-03-09 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
| WO2017053885A1 (en) | 2015-09-25 | 2017-03-30 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
| PT109154B (pt) * | 2016-02-12 | 2019-11-05 | Univ De Coimbra | Tecnologia não-invasiva de inserto ocular para libertação controlada de fármacos |
| JP7003110B2 (ja) | 2016-04-20 | 2022-01-20 | ドーズ メディカル コーポレーション | 生体吸収性眼球薬物送達デバイス |
| EP4147674A1 (en) | 2016-06-06 | 2023-03-15 | Omega Ophthalmics LLC | Prosthetic capsular device |
| WO2018075932A1 (en) | 2016-10-21 | 2018-04-26 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
| EP3630042A4 (en) * | 2017-05-30 | 2021-06-23 | Eximore Ltd. | COMPOSITIONS AND METHODS OF TREATMENT OF DRY EYE BY RELEASE OF ANTIBIOTIC MACROLIDE |
| CA3095098A1 (en) | 2018-04-06 | 2019-10-10 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
| EP3803866A4 (en) | 2018-05-24 | 2022-03-16 | Nureva Inc. | METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS |
| KR20210013089A (ko) | 2018-05-24 | 2021-02-03 | 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 | 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치 |
| KR20210013088A (ko) | 2018-05-24 | 2021-02-03 | 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 | 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치 |
| CN112566622A (zh) * | 2018-06-19 | 2021-03-26 | 细胞疗法有限责任公司 | 用于治疗青光眼或高眼压症的包含眼内压降低剂、cnp化合物、npr-b化合物、tie-2激动剂或神经营养剂的缓释药物递送系统 |
| GB2601922B (en) | 2019-06-27 | 2024-04-24 | Layerbio Inc | Ocular device drub delivery systems |
| WO2021094468A1 (en) | 2019-11-12 | 2021-05-20 | Dsm Ip Assets B.V. | Polyesteramide copolymers possessing high glass transition temperatures |
| WO2022082170A1 (en) | 2020-10-12 | 2022-04-21 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
| US12186512B2 (en) * | 2020-10-26 | 2025-01-07 | Christopher Green | Treatment for dry eyes |
| BR112023022439A2 (pt) | 2021-04-26 | 2023-12-26 | Celanese Eva Performance Polymers Llc | Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular |
| WO2024258996A1 (en) * | 2023-06-16 | 2024-12-19 | Baylor College Of Medicine | Ocular drug delivery |
Family Cites Families (88)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3416530A (en) | 1966-03-02 | 1968-12-17 | Richard A. Ness | Eyeball medication dispensing tablet |
| US3854480A (en) * | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US3618604A (en) | 1969-06-09 | 1971-11-09 | Alza Corp | Ocular insert |
| US3630200A (en) | 1969-06-09 | 1971-12-28 | Alza Corp | Ocular insert |
| US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| US4069307A (en) | 1970-10-01 | 1978-01-17 | Alza Corporation | Drug-delivery device comprising certain polymeric materials for controlled release of drug |
| US3981303A (en) | 1971-09-09 | 1976-09-21 | Alza Corporation | Bioerodible ocular device |
| US3993071A (en) | 1971-09-09 | 1976-11-23 | Alza Corporation | Bioerodible ocular device |
| US3986510A (en) | 1971-09-09 | 1976-10-19 | Alza Corporation | Bioerodible ocular device |
| US3948254A (en) | 1971-11-08 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
| US3828777A (en) | 1971-11-08 | 1974-08-13 | Alza Corp | Microporous ocular device |
| SE375007B (enExample) | 1972-11-30 | 1975-04-07 | Pharmacia Ab | |
| US4177256A (en) | 1973-04-25 | 1979-12-04 | Alza Corporation | Osmotic bursting drug delivery device |
| US3961628A (en) | 1974-04-10 | 1976-06-08 | Alza Corporation | Ocular drug dispensing system |
| US4142526A (en) | 1974-12-23 | 1979-03-06 | Alza Corporation | Osmotic releasing system with means for changing release therefrom |
| US4014335A (en) | 1975-04-21 | 1977-03-29 | Alza Corporation | Ocular drug delivery device |
| US4052505A (en) | 1975-05-30 | 1977-10-04 | Alza Corporation | Ocular therapeutic system manufactured from copolymer |
| US4144317A (en) | 1975-05-30 | 1979-03-13 | Alza Corporation | Device consisting of copolymer having acetoxy groups for delivering drugs |
| US4057619A (en) | 1975-06-30 | 1977-11-08 | Alza Corporation | Ocular therapeutic system with selected membranes for administering ophthalmic drug |
| GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
| US4164560A (en) | 1977-01-05 | 1979-08-14 | Folkman Moses J | Systems for the controlled release of macromolecules |
| US4391797A (en) | 1977-01-05 | 1983-07-05 | The Children's Hospital Medical Center | Systems for the controlled release of macromolecules |
| US4186184A (en) | 1977-12-27 | 1980-01-29 | Alza Corporation | Selective administration of drug with ocular therapeutic system |
| US4190642A (en) | 1978-04-17 | 1980-02-26 | Alza Corporation | Ocular therapeutic system for dispensing a medication formulation |
| US4281654A (en) | 1980-04-07 | 1981-08-04 | Alza Corporation | Drug delivery system for controlled ocular therapy |
| US4278087A (en) | 1980-04-28 | 1981-07-14 | Alza Corporation | Device with integrated operations for controlling release of agent |
| US4765989A (en) | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| US4753652A (en) | 1984-05-04 | 1988-06-28 | Children's Medical Center Corporation | Biomaterial implants which resist calcification |
| US4663147A (en) | 1985-09-03 | 1987-05-05 | International Minerals & Chemical Corp. | Disc-like sustained release formulation |
| CA1330886C (en) | 1988-01-22 | 1994-07-26 | Bend Research Inc. | Osmotic system for delivery of dilute solutions |
| US5185152A (en) | 1990-01-10 | 1993-02-09 | Peyman Gholam A | Method and apparatus for controlled release drug delivery to the cornea and anterior chamber of the eye |
| AU7998091A (en) | 1990-05-17 | 1991-12-10 | Harbor Medical Devices, Inc. | Medical device polymer |
| US5378475A (en) | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
| US5302397A (en) | 1991-11-19 | 1994-04-12 | Amsden Brian G | Polymer-based drug delivery system |
| US5178635A (en) | 1992-05-04 | 1993-01-12 | Allergan, Inc. | Method for determining amount of medication in an implantable device |
| FR2692812B1 (fr) | 1992-06-24 | 1994-12-30 | Flamel Tech Sa | Microcapsules contenant au moins un principe actif, leurs applications et procédé de préparation de microcapsules renfermant au moins un principe actif. |
| DE69435002T2 (de) | 1993-07-19 | 2008-03-20 | Angiotech Pharmaceuticals, Inc., Vancouver | Anti-angiogene Mittel enthaltend Taxol und einen nicht biodegradierbaren Träger und deren Verwendung |
| US20030203976A1 (en) | 1993-07-19 | 2003-10-30 | William L. Hunter | Anti-angiogenic compositions and methods of use |
| US5443505A (en) | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
| US5877224A (en) | 1995-07-28 | 1999-03-02 | Rutgers, The State University Of New Jersey | Polymeric drug formulations |
| US5773019A (en) | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
| US6196993B1 (en) * | 1998-04-20 | 2001-03-06 | Eyelab Group, Llc | Ophthalmic insert and method for sustained release of medication to the eye |
| US6423345B2 (en) | 1998-04-30 | 2002-07-23 | Acusphere, Inc. | Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| EP1554990A3 (en) | 1999-01-29 | 2008-08-06 | Medtronic, Inc. | Implantable medical device with enhanced biocompatibility and biostability |
| US6416777B1 (en) | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
| DE60040876D1 (de) | 1999-10-21 | 2009-01-02 | Alcon Inc | Medikamentenzuführeinrichtung |
| IL143477A (en) | 2001-05-31 | 2009-07-20 | Finetech Pharmaceutical Ltd | Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives |
| US20040208910A1 (en) * | 2000-04-26 | 2004-10-21 | Control Delivery Systems, Inc. | Sustained release device and method for ocular delivery of adrenergic agents |
| PE20020146A1 (es) | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
| WO2002043785A2 (en) | 2000-11-29 | 2002-06-06 | Oculex Pharmaceuticals, Inc. | Intraocular implants for preventing transplant rejection in the eye |
| DE60137542D1 (de) * | 2001-01-03 | 2009-03-12 | Bausch & Lomb | Wirkstoffabgabevorrichtungen mit verzögerter freisetzung mehrere stoffe enthaltend |
| US6713081B2 (en) | 2001-03-15 | 2004-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Ocular therapeutic agent delivery devices and methods for making and using such devices |
| PT1420716E (pt) | 2001-08-29 | 2012-11-21 | Ricardo A P De Carvalho | Um sistema implantável e selável destinado à administração unidireccional de agentes terapêuticos em tecidos-alvo |
| US20030059466A1 (en) | 2001-09-14 | 2003-03-27 | Pawan Seth | Delayed release tablet of venlafaxin |
| AU2004207507B2 (en) * | 2003-01-24 | 2009-11-19 | Eyepoint Pharmaceuticals Us, Inc. | Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors |
| US20050079199A1 (en) | 2003-02-18 | 2005-04-14 | Medtronic, Inc. | Porous coatings for drug release from medical devices |
| US20060167435A1 (en) | 2003-02-18 | 2006-07-27 | Adamis Anthony P | Transscleral drug delivery device and related methods |
| CA2523859C (en) | 2003-04-29 | 2011-08-02 | The General Hospital Corporation | Methods and devices for the sustained release of multiple drugs |
| AU2004292957C1 (en) | 2003-11-13 | 2011-04-28 | Eyepoint Pharmaceuticals Us, Inc. | Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin |
| US7211272B2 (en) | 2003-12-22 | 2007-05-01 | Bausch & Lomb Incorporated | Drug delivery device |
| US7976858B2 (en) | 2004-01-13 | 2011-07-12 | The Hospital For Special Surgery | Drug delivery to a joint |
| GB0401947D0 (en) | 2004-01-28 | 2004-03-03 | Unilever Plc | Porous bodies and method of production thereof |
| WO2005077528A1 (en) | 2004-02-05 | 2005-08-25 | Millipore Corporation | Porous adsorptive or chromatographic media |
| US20050232972A1 (en) | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
| US7820732B2 (en) | 2004-04-30 | 2010-10-26 | Advanced Cardiovascular Systems, Inc. | Methods for modulating thermal and mechanical properties of coatings on implantable devices |
| US8673341B2 (en) | 2004-04-30 | 2014-03-18 | Allergan, Inc. | Intraocular pressure reduction with intracameral bimatoprost implants |
| US20050244469A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Extended therapeutic effect ocular implant treatments |
| US7799336B2 (en) * | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
| JP2008509240A (ja) | 2004-08-03 | 2008-03-27 | エイジェンシー フォー サイエンス，テクノロジー アンド リサーチ | 薬物送達のための連続孔を有するポリマー及び方法 |
| FR2875409B1 (fr) | 2004-09-17 | 2010-05-07 | Sanofi Aventis | Composition pharmaceutique comprenant une dispersion solide a matrice polymere comprenant une phase continue de polydextrose et une phase continue d'un polymere autre que du polydextrose |
| US20060247266A1 (en) * | 2004-11-26 | 2006-11-02 | Asahi Kasei Pharma Corporation | Nitrogen-containing tricyclic compounds |
| US20060134174A1 (en) | 2004-12-22 | 2006-06-22 | Bausch & Lomb Incorporated | Pharmaceutical delivery system and method of use |
| US20070009564A1 (en) | 2005-06-22 | 2007-01-11 | Mcclain James B | Drug/polymer composite materials and methods of making the same |
| US20070212397A1 (en) | 2005-09-15 | 2007-09-13 | Roth Daniel B | Pharmaceutical delivery device and method for providing ocular treatment |
| WO2007034140A1 (en) | 2005-09-21 | 2007-03-29 | Aston University | Chronotherapeutic ocular delivery system comprising a combination of prostaglandin and a beta-blocker for treating primary glaucoma |
| US20070260203A1 (en) | 2006-05-04 | 2007-11-08 | Allergan, Inc. | Vasoactive agent intraocular implant |
| US20070298073A1 (en) * | 2006-06-23 | 2007-12-27 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
| US8802128B2 (en) | 2006-06-23 | 2014-08-12 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
| US20080057103A1 (en) | 2006-08-21 | 2008-03-06 | Wouter Roorda | Methods of using medical devices for controlled drug release |
| KR20100033400A (ko) | 2007-06-06 | 2010-03-29 | 바스프 에스이 | 급속 붕해 정제의 제조를 위한 제약 제제 |
| DE102008012295A1 (de) | 2008-03-03 | 2009-09-17 | Südzucker AG Mannheim/Ochsenfurt | Gemisch zur Herstellung von schnell zerfallenden Tabletten |
| US20100104654A1 (en) | 2008-10-27 | 2010-04-29 | Allergan, Inc. | Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
| US8722739B2 (en) * | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| US20100158980A1 (en) | 2008-12-18 | 2010-06-24 | Casey Kopczynski | Drug delivery devices for delivery of therapeutic agents |
| CA2785468A1 (en) | 2009-12-23 | 2011-06-30 | Psivida Us, Inc. | Sustained release delivery devices |
| EP2555749B1 (en) | 2010-04-06 | 2016-10-26 | Allergan, Inc. | Sustained-release reservoir implants for intracameral drug delivery |
| EP2571526B1 (en) | 2010-05-17 | 2019-03-13 | Novaer Holdings, Inc. | Drug delivery devices for delivery of ocular therapeutic agents |
-
2011
- 2011-05-17 EP EP11784089.2A patent/EP2571526B1/en active Active
- 2011-05-17 AU AU2011256259A patent/AU2011256259A1/en not_active Abandoned
- 2011-05-17 CA CA2798084A patent/CA2798084A1/en not_active Abandoned
- 2011-05-17 WO PCT/US2011/036806 patent/WO2011146483A1/en not_active Ceased
- 2011-05-17 JP JP2013511293A patent/JP2013526572A/ja active Pending
- 2011-05-17 US US13/642,042 patent/US20130142858A1/en not_active Abandoned
-
2013
- 2013-07-22 US US13/947,564 patent/US8765166B2/en active Active
-
2015
- 2015-12-22 US US14/978,879 patent/US9808420B2/en active Active
-
2017
- 2017-10-18 US US15/787,600 patent/US10869833B2/en active Active
-
2020
- 2020-12-21 US US17/129,151 patent/US20210251892A1/en not_active Abandoned
-
2022
- 2022-08-12 US US17/887,261 patent/US20230094779A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013526572A5 (enExample) | ||
| JP2017524685A5 (enExample) | ||
| IL294463A (en) | Methods for treating or preventing eye conditions | |
| RU2014133501A (ru) | Способ лечения повышенного внутриглазного давления с помощью внутриглазной системы доставки лекарственного средства с замедленным высвобождением | |
| WO2014165308A3 (en) | Microsphere drug delivery system for sustained intraocular release | |
| JP2017522292A5 (enExample) | ||
| JP2015025011A5 (enExample) | ||
| JP2009501797A5 (enExample) | ||
| PH12019550088A1 (en) | Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery | |
| JP2012533517A5 (enExample) | ||
| JP2013006877A5 (enExample) | ||
| RU2018128980A (ru) | Офтальмологические составы для доставки лекарственных средств к заднему сегменту глаза | |
| JP2017532363A5 (enExample) | ||
| JP2011520805A5 (enExample) | ||
| AR103981A1 (es) | Métodos y composiciones particularmente para el tratamiento del trastorno por déficit de atención | |
| JP2014139241A5 (enExample) | ||
| JP2011529854A5 (enExample) | ||
| RU2012139802A (ru) | Композиции с контролируемым высвобождением на основе кортикостероидов для лечения ушных болезней | |
| AR070824A1 (es) | Suspensiones para inyeccion intravitrea de triamcinolona acetonido de baja viscosidad, altamente floculadas | |
| JP2013525493A5 (enExample) | ||
| WO2014106116A3 (en) | Therapeutic compositions comprising antibodies | |
| JP2014012746A5 (enExample) | ||
| JP2013525335A5 (enExample) | ||
| WO2015099985A3 (en) | Cationic materials and formulations for drug delivery | |
| JP2018507252A5 (enExample) |